PAUL STEVEN M bought Rapport Therapeutics Inc ($RAPP) shares on the open market twice in the last year, for a total of $1.03 million. His most recent purchase was on September 12, 2025. These buys rank 484th among 4,983 insiders, below the average of $1.46 million across 3.29 transactions. He made no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 12, 2025 | Rapport Therapeutics, Inc. | $RAPP | PAUL STEVEN M | Not found | P | Common Stock | 28284 | $24.50 | 28,284.0000 | 36,496,437 | 9999.99% | 0.08% |
| Sept. 12, 2025 | Rapport Therapeutics, Inc. | $RAPP | PAUL STEVEN M | Not found | P | Common Stock | 13382 | $24.97 | 41,666.0000 | 36,496,437 | 47.31% | 0.04% |
| June 17, 2025 | Rapport Therapeutics, Inc. | $RAPP | PAUL STEVEN M | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| Jan. 3, 2024 | Sage Therapeutics, Inc. | $SAGE | PAUL STEVEN M | Not found | A | Stock Options (Right to buy) | 3971 | $0.00 | 3,971.0000 | 0 | 9999.99% | 0.00% |